These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. Okada T; Wakabayashi M; Ikeda K; Matsuzaki K J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434 [TBL] [Abstract][Full Text] [Related]
23. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. Schmidt C; Lepsverdize E; Chi SL; Das AM; Pizzo SV; Dityatev A; Schachner M Mol Psychiatry; 2008 Oct; 13(10):953-69. PubMed ID: 17726461 [TBL] [Abstract][Full Text] [Related]
24. Small molecule beta-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer's disease. Hawkes CA; Deng LH; Shaw JE; Nitz M; McLaurin J Eur J Neurosci; 2010 Jan; 31(2):203-13. PubMed ID: 20074226 [TBL] [Abstract][Full Text] [Related]
25. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927 [TBL] [Abstract][Full Text] [Related]
26. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology. Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568 [TBL] [Abstract][Full Text] [Related]
27. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525 [TBL] [Abstract][Full Text] [Related]
28. A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro. Nakagami Y; Nishimura S; Murasugi T; Kaneko I; Meguro M; Marumoto S; Kogen H; Koyama K; Oda T Br J Pharmacol; 2002 Nov; 137(5):676-82. PubMed ID: 12381681 [TBL] [Abstract][Full Text] [Related]
29. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
30. Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein. Heredia L; Lin R; Vigo FS; Kedikian G; Busciglio J; Lorenzo A Neurobiol Dis; 2004 Aug; 16(3):617-29. PubMed ID: 15262274 [TBL] [Abstract][Full Text] [Related]
31. Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention. Yang DS; Serpell LC; Yip CM; McLaurin J; Chrishti MA; Horne P; Boudreau L; Kisilevsky R; Westaway D; Fraser PE Amyloid; 2001 Jul; 8 Suppl 1():10-9. PubMed ID: 11676284 [TBL] [Abstract][Full Text] [Related]
32. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Adlard PA; Cherny RA; Finkelstein DI; Gautier E; Robb E; Cortes M; Volitakis I; Liu X; Smith JP; Perez K; Laughton K; Li QX; Charman SA; Nicolazzo JA; Wilkins S; Deleva K; Lynch T; Kok G; Ritchie CW; Tanzi RE; Cappai R; Masters CL; Barnham KJ; Bush AI Neuron; 2008 Jul; 59(1):43-55. PubMed ID: 18614028 [TBL] [Abstract][Full Text] [Related]
33. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42. Finder VH; Vodopivec I; Nitsch RM; Glockshuber R J Mol Biol; 2010 Feb; 396(1):9-18. PubMed ID: 20026079 [TBL] [Abstract][Full Text] [Related]
35. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. De Ferrari GV; Chacón MA; Barría MI; Garrido JL; Godoy JA; Olivares G; Reyes AE; Alvarez A; Bronfman M; Inestrosa NC Mol Psychiatry; 2003 Feb; 8(2):195-208. PubMed ID: 12610652 [TBL] [Abstract][Full Text] [Related]
36. The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity. Stege GJ; Renkawek K; Overkamp PS; Verschuure P; van Rijk AF; Reijnen-Aalbers A; Boelens WC; Bosman GJ; de Jong WW Biochem Biophys Res Commun; 1999 Aug; 262(1):152-6. PubMed ID: 10448084 [TBL] [Abstract][Full Text] [Related]
37. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies. Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106 [TBL] [Abstract][Full Text] [Related]
38. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid. Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579 [TBL] [Abstract][Full Text] [Related]